20 May 2024
AstraZeneca plans $1.5 billion manufacturing facility
for antibody drug conjugates (ADCs) in Singapore
Operationally ready by 2029, it will be…
15 May 2024 15:00 BST
Transaction by Person Discharging Managerial Responsibilities
AstraZeneca PLC (the Company) announced that on 13 May 2024, Pascal…
BenevolentAI (AMS:BAI, OTC:BAIVF) told investors it has reached an important milestone in its collaboration with AstraZeneca, helping the drug-maker add…